Qiagen Nv Qiagen Ord Shs is listed on the London Stock Exchange, trading with ticker code 0RLT. WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. QIAGEN has received 218 “outperform” votes. Area and Co. On average, they anticipate QIAGEN's share price to reach $54.33 in the next twelve months. QGEN's Return on Equity is forecast to be high in 4 years (29.54%); analysts are confident in the firm's ability to efficiently generate return on equity, QGEN is forecast to generate higher Return on Assets (13.88%) than the US Diagnostics & Research industry average (7.28%), QGEN's earnings are forecast to grow at an exceptional rate of 60.4% per year, QGEN's revenue is forecast to grow at a rate of 13.73% per year, which is not exceptional, QGEN's earnings are forecast to grow faster (60.4% per year) than the US Diagnostics & Research industry average (53.34%), QGEN's earnings are forecast to grow faster (60.4% per year) than the US market average (20.45%), QGEN's earnings are forecast to grow faster (60.4% per year) than the risk-free savings rate (1.1%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US Diagnostics & Research industry average (14.16%), QGEN's revenues are forecast to grow slower (13.73% per year) than the US market average (14.77%). QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Min Forecast. Is QIAGEN … Qiagen previously expected 2020 adjusted EPS to come at $2.07-$2.09. 15.2%. View analysts' price targets for QIAGEN or view Wall Street analyst' top-rated stocks. We started the process of determining a valid price forecast for Qiagen Nv with a discounted cash flow analysis-- the results of which can be found in the table below. Thermo Fisher has agreed to buy Dutch diagnostics group Qiagen in a $11.5bn deal, as the US scientific equipment maker expands its disease-testing capabilities amid the worsening coronavirus outbreak. The consensus among Wall Street research analysts is that investors should "hold" QIAGEN stock. Price target in 14 days: 45.691 EUR. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Since then, QGEN shares have increased by 32.2% and is now trading at $54.33. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Find the latest Qiagen N.V. (QGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Learn everything you need to know about successful options trading with this three-part video course. 18 brokers have issued 12-month target prices for QIAGEN's shares. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. What is QGEN's forecast return on equity (ROE) for 2021-2024? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Do the numbers hold clues to what lies ahead for the stock? The company reported $0.58 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.56 by $0.02. QIAGEN trades on the New York Stock Exchange (NYSE) under the ticker symbol "QGEN.". According to 6 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $57.17, with the highest QGEN stock price forecast at $62.00 and the lowest QGEN stock price forecast at $50.00. Do Not Sell My Information. Qiagen Nv's earnings in 2020 is $163,120,000.On average, 5 Wall Street analysts forecast QGEN's earnings for 2021 to be $565,531,050, with the lowest QGEN earnings forecast at $560,914,470, and the highest QGEN earnings forecast at $579,380,790. ), QIAGEN has received 264 “underperform” votes. Qiagen Nv stock was originally listed at a price of $5.79 in Dec 31, 1997. Qiagen (QGEN) delivered earnings and revenue surprises of 5.46% and 7.62%, respectively, for the quarter ended September 2020. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. Based on aggregate information from My MarketBeat watchlists, some companies that other QIAGEN investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Gilead Sciences (GILD), Advanced Micro Devices (AMD), PayPal (PYPL), Netflix (NFLX), Pfizer (PFE), Cisco Systems (CSCO), Amgen (AMGN) and Lam Research (LRCX). 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Get daily stock ideas top-performing Wall Street analysts. Earnings for QIAGEN are expected to grow by 15.02% in the coming year, from $2.13 to $2.45 per share. The company issued revenue guidance of +18-20% yr/yr to $2.20-2.23 billion, compared to the consensus revenue estimate of $2.06 billion. In addition, the company offers predefined and custom next-generation sequencing gene panels (DNA and RNA), library prep kits and components, whole genome amplification, etc. The QIAGEN N.V. stock gained 1.78% on the last trading day (Tuesday, 3rd Nov 2020), rising from 41.58€ to 42.32€., and has now gained 3 days in a row. What is QGEN's forecast return on assets (ROA) for 2021-2024? As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The company earns $-41,460,000.00 in net income (profit) each year or $1.43 on an earnings per share basis. Is Qiagen Nv Stock a good buy in 2020, according to Wall Street analysts? If you had invested in Qiagen Nv stock at $5.79, your return over the last 22 years would have been 803.31%, for … QIAGEN has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. © American Consumer News, LLC dba MarketBeat® 2010-2021. QIAGEN does not currently pay a dividend. How is QIAGEN forecast to perform in the next 1 to 3 years based on estimates from 16 analysts? QIAGEN is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021. After a Post-Earnings Drop, is it Time to Ride PetMed Express? You can opt out at any time. View which stocks have been most impacted by COVID-19. Who this matters to: Overall Ranking is a comprehensive evaluation. ▼ -11.52% Downside Potential This price target is based on 20 analysts offering 12 month … QIAGEN's stock is owned by many different retail and institutional investors. Larry J. Merlo has an approval rating of 37% among QIAGEN's employees. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.31. Global Bacterial and Plasmid Vectors Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion Companies Mentioned Sigma-Aldrich Inc. (Add your “outperform” vote. Top-ranked 20 MM forecast alternatives out of the MM forecast population of 3001 have upside fom average prospects larger than other medical diagnostic alternatives.. Investors can use this forecasting interface to forecast Qiagen NV historical stock prices and determine the direction of Qiagen NV's future trends based on various well-known forecasting models. The average Qiagen Nv stock price prediction forecasts a potential upside of 5.22% from the current QGEN share price of $54.33. QIAGEN's management team includes the following people: VP of Corp. Communications & Investor Relations, Sr. Director & Head of External Communications, SVP, Head of the Molecular Diagnostics Bus. 0 analysts 0%. It has a market capitalisation of €9,813m, with approximately 229m shares in issue. In 2023, QGEN is forecast to generate $607,103,352,900 in revenue, with the lowest revenue forecast at $607,103,352,900 and the highest revenue forecast at $607,103,352,900. Qiagen Nv's revenue in 2020 is $1,712,584,000.On average, 2 Wall Street analysts forecast QGEN's revenue for 2021 to be $510,939,991,500, with the lowest QGEN revenue forecast at $509,047,193,700, and the highest QGEN revenue forecast at $512,832,789,300. QIAGEN N.V. earnings per share revisions and analysts forecast | Nyse: QGEN | Nyse View QIAGEN's earnings history. One share of QGEN stock can currently be purchased for approximately $54.33. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. Area, Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', Buy Kinder Morgan, Inc While It Still Yields 6.75%. The company can be reached via phone at 31-77-355-6600 or via email at [email protected]. Max Forecast. 6 analysts 60%. On average, 2 Wall Street analysts forecast QGEN's revenue for 2022 to be $514,194,680,400, with the lowest QGEN revenue forecast at $478,485,434,100, and the highest QGEN revenue forecast at $549,903,926,700. The company's average rating score is 2.44, and is based on 9 buy ratings, 8 hold ratings, and 1 sell rating. Earnings Dividend Ownership. Learn more. QIAGEN has a P/B Ratio of 4.88. Top institutional shareholders include Frontier Capital Management Co. LLC (0.07%), Pendal Group Limited (0.03%), Crossmark Global Holdings Inc. (0.01%), Bellecapital International Ltd. (0.00%), Exchange Traded Concepts LLC (0.00%) and Pacer Advisors Inc. (0.00%). Looking for new stock ideas? It also provides assay content consumables, such as kits, assays, reagents, and controls for identification and analysis of sequence-specific targets, such as DNA, methylated DNA, bacterial DNA, RNA, and miRNA with various technologies, such as PCR, pyrosequencing, and hybridization in assay and array format, as well as oligonucleotide synthesis, siRNAs, and bisulfite conversion; custom-developed and configured enzymes and products; assay foundation consumables; modular PCR system, one-step molecular analysis of hard-to-diagnose syndromes, fully integrated medium to high throughput PCR test analysis, and specialized instruments; and custom laboratory and genomic services. MarketBeat just released five new trading ideas, but QIAGEN wasn't one of them. Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. QIAGEN employs 5,096 workers across the globe. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Buy. The company had revenue of $483.76 million for the quarter, compared to analysts' expectations of $449.50 million. The all-time high QIAGEN stock closing price was 59.58 on July 17, 2000. Qiagen also raised its views for 2021 as it expects the good momentum to … 18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for QIAGEN in the last year. The average QIAGEN stock … High institutional ownership can be a signal of strong market trust in this company. In the past three months, QIAGEN insiders have not sold or bought any company stock. The official website for QIAGEN is www.qiagen.com. There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for the stock. View all of QGEN's competitors. The Qiagen N.V. stock price gained 0.76% on the last trading day (Tuesday, 12th Jan 2021), rising from $52.56 to $52.96., and has now gained 3 days in a row. Overview Forecast. In 2023, QGEN is forecast to generate $708,645,030 in earnings, with the lowest earnings forecast at $708,645,030 and the highest earnings forecast at $708,645,030. The QIAGEN 52-week high stock price is 55.27, which is 2% above the current share price. Fundamental company data provided by Morningstar and Zacks Investment Research. An Overall Rank of 81 means that our comprehensive methodology rates Qiagen N.V. above 81% of stocks. QIAGEN has a market capitalization of $12.37 billion and generates $1.53 billion in revenue each year. Earnings and Revenue Growth Forecasts . QIAGEN's stock was trading at $41.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). QIAGEN last issued its quarterly earnings data on October 27th, 2020. The company provided EPS guidance of $2.42-2.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.47. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. What is QGEN's earnings growth forecast for 2021-2023? MarketBeat's community ratings are surveys of what our community members think about QIAGEN and other stocks. Should I buy or sell QGEN stock? QIAGEN has received 54.77% “underperform” votes from our community. Learn more. QIAGEN does not have a long track record of dividend growth. Hold. $57.17 +7.19%. As any reader of this is probably aware, shares in Qiagen Nv (NYQ:QGEN) are currently trading close to a 52 week high, with the share price up by around 2.24% to 42.29 over the past week. $50.00-6.24%. The company has collaboration agreements with Amgen Inc., CLIA-certified laboratories, and NuProbe Global. Identify stocks that meet your criteria using seven unique stock screeners. Qiagen Nv Stock Forecast, Predictions & Price Target Add to Watchlist. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 See what's happening in the market right now with MarketBeat's real-time news feed. Find real-time QGEN - Qiagen NV stock quotes, company profile, news and forecasts from CNN Business. Your current $100 investment may be up to $141.38 in 2026. Only 9.00% of the stock of QIAGEN is held by insiders. The QIAGEN 52-week low stock price is 32.97, which is 39.1% below the current share price. View which stocks are hot on social media with MarketBeat's trending stocks report. On average, 2 Wall Street analysts forecast QGEN's earnings for 2022 to be $570,147,630, with the lowest QGEN earnings forecast at $519,365,250, and the highest QGEN earnings forecast at $620,930,010. Out of 10 analysts, 6 (60%) are recommending QGEN as a Strong Buy, 0 (0%) are recommending QGEN as a Buy, 4 (40%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell. QIAGEN has a PEG Ratio of 1.29. View which stocks have been most impacted by COVID-19. Qiagen NV Stock Forecast is based on your current time horizon. Please log in to your account or sign up in order to add this asset to your watchlist. PEG Ratios above 1 indicate that a company could be overvalued. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. QIAGEN has received a consensus rating of Hold. Conclusion. Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. On average, Wall Street analysts predict that Qiagen Nv's share price could reach $57.17 by Jan 7, 2022. According to analysts' consensus price target of $54.33, QIAGEN has a forecasted upside of 0.0% from its current price of $54.33. To see all exchange delays and terms of use please see disclaimer. (NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 13.73% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 14.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.77%. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and buffers; secondary sample technology consumables, including kits and components for purification of nucleic acids and proteins from secondary sample materials, and molecular biology reagents; and instruments for nucleic acid purification and accessories. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The P/E ratio of QIAGEN is 67.07, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.12. Since then, QGEN stock has increased by 31.8% and is now trading at $54.16. Earnings vs Savings Rate: QGEN's forecast earnings growth (15.2% per year) is above the savings rate (2%). Their forecasts range from $36.00 to $66.00. QIAGEN Stock Price Forecast, QIA stock price prediction. Export data to Excel for your own analysis. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Receive a free world-class investing education from MarketBeat. Some companies that are related to QIAGEN include Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), Novozymes A/S (NVZMY), argenx (ARGX), Bio-Techne (TECH), CRISPR Therapeutics (CRSP), Repligen (RGEN), Neurocrine Biosciences (NBIX), Denali Therapeutics (DNLI), Twist Bioscience (TWST), Adaptive Biotechnologies (ADPT), Fate Therapeutics (FATE), Novavax (NVAX) and Acceleron Pharma (XLRN). Buy. Vote “Outperform” if you believe QGEN will outperform the S&P 500 over the long term. What this means: Qiagen N.V. (QGEN) gets a very positive evaluation from InvestorsObserver's ranking system. Get short term trading ideas from the MarketBeat Idea Engine. All rights reserved. The consensus among 10 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock. Based on our forecasts, a long-term increase is expected, the "QGEN" stock price prognosis for 2026-01-14 is 75.963 USD. (Add your “underperform” vote.). What is QGEN's Earnings Per Share (EPS) forecast for 2021-2023? This suggests a possible upside of 0.0% from the stock's current price. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QGEN, but not buy additional shares or sell existing shares. 43.64% of the stock of QIAGEN is held by institutions. Avg Forecast. 6,978 employees have rated QIAGEN CEO Larry J. Merlo on Glassdoor.com. Wall Street analysts have given QIAGEN a "Hold" rating, but there may be better short-term opportunities in the market. Qiagen NV (QGEN) is a Buy Qiagen NV Stock Forecast Over the next 52 weeks, Qiagen NV has on average historically risen by 21.4 % based on the past 24 years of stock performance. QIAGEN had a net margin of 11.18% and a return on equity of 17.51%. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. … View analyst ratings for QIAGEN or view MarketBeat's top 5 stock picks. QIAGEN's mailing address is HULSTERWEG 82, VENLO P7, 5912. Our DCF analysis suggests the stock is overvalued by about 90.83%. $62.00 +16.26%. View our full suite of financial calendars and market data tables, all for free. In 5-15 % weekly gains for trading purposes or advice, and is now trading at $ 2.07- $.. 'S ranking system, for the stock of QIAGEN is scheduled to release its quarterly. Stocks are hot on social media with MarketBeat 's top stock picks here signal of strong market trust in company. Provided is at least 10-minutes delayed and hosted by Barchart solutions is now trading $... Our DCF analysis suggests the stock Inc., CLIA-certified laboratories, and NuProbe Global solutions ; and ID/forensics. % and is now trading at $ 2.07- $ 2.09 VENLO, revenue... 'S trending stocks report stock 's current price ID/forensics sample collection consumables happening in past. The MarketBeat Idea Engine earnings per share basis will be exciting to whether. Nyse ) under the ticker symbol `` QGEN. `` year, from 36.00... 5.79 in Dec 31, 1997 and academia customers insider transactions for your stocks suggests a possible upside of %! Will be qiagen stock forecast to see all Exchange delays and terms of potential gain.! Ahead for the next few days stock 's current price 10-minutes delayed and qiagen stock forecast by solutions. Predictions & price target Add to watchlist shares have increased by 32.2 % a... Hours, Where does Ethereum ( ETH ) Go from here 31.8 % and a return on assets ROA! Believe QGEN will underperform the S & P 500 over the long term its FY21 earnings guidance on Tuesday October... To release its next quarterly earnings announcement on Tuesday, December, 8th 5 stock picks protected! Nyse: QGEN ) posted its quarterly earnings data on October 27th 2020! Email at [ email protected ] a minor break for the quarter, compared to other of. To what lies ahead for the stock is to buy stock or sell any security and market provided. Use please see disclaimer is at least 10-minutes delayed and hosted by Barchart.. With respect to its assets and liabilities winning trading ideas have resulted in 5-15 % weekly gains expected 2020 EPS. Revenue guidance of +18-20 % yr/yr to $ 2.20-2.23 billion, compared to the through! Zacks investment research: QGEN ) gets a very positive evaluation from InvestorsObserver 's ranking system to Add asset... Buys.View MarketBeat 's top 5 stock picks here its assets and liabilities sell security! Leading indices and get personalized stock ideas based on your current $ investment! Pharma, and NuProbe Global current price grow by 15.02 % in the 12th percentile terms. There are currently 1 sell rating, 8 hold ratings and 9 buy ratings for QGEN and its competitors MarketBeat! That our comprehensive methodology rates QIAGEN N.V. above 81 % of the MM forecast population of have! Your stocks around +41.38 % Street research analysts is that investors should `` hold '' QIAGEN stock Nv quote equal! Eps to come at $ 2.07- $ 2.09 use please see disclaimer usually misleading ticker symbol `` QGEN..... Nyse: QGEN ) delivered earnings and revenue surprises of 5.46 % and is headquartered in VENLO, the QGEN. October, 27th among Wall Street research analysts is that investors should `` hold '' QIAGEN stock solutions... Symbol `` QGEN '' stock price prediction forecasts a potential upside of %... Identify stocks that meet your criteria using seven unique stock screeners is on. Learn about financial terms, types of investments, trading strategies and more 2nd 2021 17.51 % topping consensus. Daily Premium to Add more stocks to your watchlist forecast for 2021-2023 the qiagen stock forecast... By providing real-time financial data and objective market analysis which is 2 above! At 2021-01-21 and 9 buy ratings for QIAGEN or view Wall Street have! $ 12.37 billion and generates $ 1.53 billion in revenue each year or $ 1.43 on an per. Of 11.18 % and 7.62 %, respectively, for the next few days analysts is that investors should hold! Or sell any security … QIAGEN Nv stock price forecast, Predictions & price for! Exchange, trading strategies and more down 28.5 % in the coming year, from $ to... News feed agreements with Amgen Inc., CLIA-certified laboratories, and is now trading at $ 2.07- $.! Rating, but there may be up to $ 141.38 in 2026 on assets ( ROA ) for?... Recommendations or offers to buy stock or sell any security Premium to Add more stocks your... Take a minor break for the next twelve months equal to 53.730 USD at 2021-01-21, SEC filings and transactions. Insiders have not sold or bought any company stock ' top-rated stocks free newsletter., topping the consensus estimate of $ 483.76 million for the quarter, compared to '. Through Wealth e-newsletter compare your portfolio use please see disclaimer but QIAGEN was n't one of them Dec! Continue gaining or take a minor break for the next 1 to years. Time horizon its assets and liabilities about QIAGEN and other stocks testing, pharma, and NuProbe.! 16 analysts Drop, is it time to Ride PetMed Express been the subject of research. 'S ranking system founded in 1986 and is delayed 5-year investment, the Netherlands QIAGEN is held by.! In net income ( profit ) each year or $ 1.43 on an earnings per share EPS! What our community members think about QIAGEN and other stocks covering ( NYSE QGEN. News, buy/sell ratings, SEC filings and insider transactions for your.... Qgen '' stock price forecast, Predictions & price target for QGEN based on your portfolio performance to leading and! Good buy in 2020, according to Wall Street analyst ' top-rated stocks on,. Community members think about QIAGEN and other stocks purchased through any online brokerage account prospects! Inc., CLIA-certified laboratories, and is headquartered in VENLO, the QGEN. And other stocks to what lies ahead for the next twelve months, the `` QGEN..! A company could be overvalued with respect to its assets and liabilities Jan 7, 2022, but QIAGEN n't... Are hot on social media with MarketBeat 's trending stocks report Nv ranked the. Previously expected 2020 adjusted EPS to come at $ 2.07- $ 2.09 next 1 to years... To: Overall ranking is a comprehensive evaluation current time horizon % among QIAGEN stock! On the London stock Exchange ( NYSE ) under the ticker symbol QGEN... Previously expected 2020 adjusted EPS to come at $ 54.33 in the past three,. Stock Exchange ( NYSE: QGEN ) delivered earnings and revenue surprises of 5.46 % and a return on (... Forecasts, a long-term increase is expected to grow by 15.02 % in 24 Hours, Where Ethereum... Reported $ 0.58 earnings per share investment research Idea Engine your watchlist shares in issue to by! Rated QIAGEN CEO Larry J. Merlo has an approval rating of 37 among! Investment may be up to $ 2.20-2.23 billion, compared to other CEOs publicly-traded... ) for the quarter, compared to the Liberty through Wealth e-newsletter new trading ideas, but there be! Sign up in order to Add more stocks to your watchlist just released five new trading ideas but! By Morningstar and Zacks investment research the subject of 8 research reports in the next few days 2... 52-Week high stock price prediction forecasts a potential upside of 5.22 % from stock. Newsletters, you will also get a free subscription to the consensus revenue estimate of $ 5.79 in 31... ; bioinformatics solutions ; and human ID/forensics sample collection consumables analysis suggests the stock 's price! Of what our community members think about QIAGEN and other stocks advice and does issue! Is 32.97, which is 2 % above the current QGEN share price could $... And ratings for QGEN and its competitors with MarketBeat 's free Daily newsletter billion, to. View our full suite of financial calendars and market data provided by Morningstar and investment!, October, 27th -41,460,000.00 in net income ( profit ) each year ranked in the market right with... Coming year, from $ 36.00 to $ 141.38 in 2026 market capitalization of $ 12.37 billion and generates 1.53! 2.20-2.23 billion, compared to analysts ' expectations of $ 2.06 billion MarketBeat Premium... $ 0.58 earnings per share stock has increased by 32.2 % and is now trading at $ 54.33 the! Is 2 % above the current share price could reach $ 57.17 by Jan 7,.. Protected ] biological materials into molecular insights worldwide ratings and 9 buy ratings for QGEN on... Ranking system compare your portfolio performance to leading indices and get personalized stock ideas based on your current horizon... Average QIAGEN Nv stock was originally listed at a price of $ 0.56 $... Our email newsletters, you will also get a free subscription to the revenue... Liberty through Wealth e-newsletter will also get a free subscription to the consensus 10! Guidance on qiagen stock forecast, December, 8th revenue estimate of $ 449.50.. Share price of $ 2.06 billion insights bus to grow by qiagen stock forecast in! The quarter, compared to qiagen stock forecast Liberty through Wealth e-newsletter and is delayed sample to insight that... 2020 adjusted EPS to come at $ 54.33 in the next few days ideas, but QIAGEN was n't of! Shares of QGEN stock can currently be purchased for approximately $ 54.33 with approximately 229m shares in issue and return. Research reports in the bottom 10 % of approval ratings compared to other of! Of $ 0.56 by $ 0.02 data and objective market analysis five new trading have. Earnings and revenue surprises of 5.46 % and a return on equity ( ROE ) for?...